Literature DB >> 25917554

Lupus nephritis: MAINTAINing perspective in lupus nephritis trials.

Brad H Rovin1, Isabelle Ayoub1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25917554     DOI： 10.1038/nrneph.2015.65

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  8 in total

Review 1.  Lupus nephritis: the evolving role of novel therapeutics.

Authors:  Brad H Rovin; Samir V Parikh
Journal:  Am J Kidney Dis       Date:  2014-01-07       Impact factor: 8.860

2.  Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.

Authors:  Zhihong Liu; Haitao Zhang; Zhangsuo Liu; Changying Xing; Ping Fu; Zhaohui Ni; Jianghua Chen; Hongli Lin; Fuyou Liu; Yongcheng He; Yani He; Lining Miao; Nan Chen; Ying Li; Yong Gu; Wei Shi; Weixin Hu; Zhengzhao Liu; Hao Bao; Caihong Zeng; Minlin Zhou
Journal:  Ann Intern Med       Date:  2015-01-06       Impact factor: 25.391

3.  Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.

Authors:  Mary Anne Dooley; David Jayne; Ellen M Ginzler; David Isenberg; Nancy J Olsen; David Wofsy; Frank Eitner; Gerald B Appel; Gabriel Contreras; Laura Lisk; Neil Solomons
Journal:  N Engl J Med       Date:  2011-11-17       Impact factor: 91.245

4.  Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.

Authors:  Chi Chiu Mok; King Yee Ying; Cheuk Wan Yim; Yui Pong Siu; Ka Hang Tong; Chi Hung To; Woon Leung Ng
Journal:  Ann Rheum Dis       Date:  2014-12-30       Impact factor: 19.103

5.  Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort.

Authors:  Maria Dall'Era; Miriam G Cisternas; Dawn E Smilek; Laura Straub; Frédéric A Houssiau; Ricard Cervera; Brad H Rovin; Meggan Mackay
Journal:  Arthritis Rheumatol       Date:  2015-05       Impact factor: 10.995

6.  Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.

Authors:  Frédéric A Houssiau; Carlos Vasconcelos; David D'Cruz; Gian Domenico Sebastiani; Enrique de Ramon Garrido Ed; Maria Giovanna Danieli; Daniel Abramovicz; Daniel Blockmans; Alessandro Mathieu; Haner Direskeneli; Mauro Galeazzi; Ahmet Gül; Yair Levy; Peter Petera; Rajko Popovic; Radmila Petrovic; Renato Alberto Sinico; Roberto Cattaneo; Josep Font; Geneviève Depresseux; Jean-Pierre Cosyns; Ricard Cervera
Journal:  Arthritis Rheum       Date:  2002-08

7.  Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.

Authors:  Frédéric A Houssiau; David D'Cruz; Shirish Sangle; Philippe Remy; Carlos Vasconcelos; Radmila Petrovic; Christoph Fiehn; Enrique de Ramon Garrido; Inge-Magrethe Gilboe; Maria Tektonidou; Daniel Blockmans; Isabelle Ravelingien; Véronique le Guern; Geneviève Depresseux; Loïc Guillevin; Ricard Cervera
Journal:  Ann Rheum Dis       Date:  2010-09-10       Impact factor: 19.103

8.  Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis.

Authors:  Farah Tamirou; David D'Cruz; Shirish Sangle; Philippe Remy; Carlos Vasconcelos; Christoph Fiehn; Maria del Mar Ayala Guttierez; Inge-Magrethe Gilboe; Maria Tektonidou; Daniel Blockmans; Isabelle Ravelingien; Véronique le Guern; Geneviève Depresseux; Loïc Guillevin; Ricard Cervera; Frédéric A Houssiau
Journal:  Ann Rheum Dis       Date:  2015-03-10       Impact factor: 19.103
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.